2019
DOI: 10.1016/j.jacc.2019.09.043
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation, Management, and Outcomes of Patients Poorly Responsive to Cardiac Resynchronization Device Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
54
1
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 70 publications
(58 citation statements)
references
References 29 publications
2
54
1
1
Order By: Relevance
“…31 Although the trajectory for LVEF after initial CRT cannot be definitively ascertained, most studies assess CRT response at 6 months or 12 months, and the majority of responders usually show improvement at 6 months. 18,19,32 In this study, the mean time from implantation of CRT to initial programming of SyncAV was 17.8 AE 8.5 months, and the results of this study assess echocardiographic parameters before and 6 months after SyncAV optimization. In addition, we used stricter cutoffs for LVEF and LVESV to increase the robustness of our results.…”
Section: Limitationsmentioning
confidence: 93%
“…31 Although the trajectory for LVEF after initial CRT cannot be definitively ascertained, most studies assess CRT response at 6 months or 12 months, and the majority of responders usually show improvement at 6 months. 18,19,32 In this study, the mean time from implantation of CRT to initial programming of SyncAV was 17.8 AE 8.5 months, and the results of this study assess echocardiographic parameters before and 6 months after SyncAV optimization. In addition, we used stricter cutoffs for LVEF and LVESV to increase the robustness of our results.…”
Section: Limitationsmentioning
confidence: 93%
“…CRT plays an important role in the treatment of chronic congestive heart failure [Separham 2019;Hoosain 2017]. It can change the sequence of myocardial activation via left ventricular pacing or biventricular pacing, thereby, improving the LVEF and hemodynamic parameters [Varma 2019;Vereckei 2018]. Many methods have been developed for placing the pacing leads.…”
Section: Discussionmentioning
confidence: 99%
“…This is in contrast with the message from all randomized controlled CRT trials in HFrEF patients with a QRS >130 ms, which consistently show a spectrum of stabilization or improvement of disease progression to even recovery of the disease 10,11 . Moreover, in addition to this ‘failure to refer’, optimization of both the device and the care of the patient following implant is hampered by a lack of integration of cardiological and non‐specialist care, leading to suboptimal and variable post‐implant management 12,13 . As a result, many heart failure patients are not exposed to the full potential benefit of CRT.…”
Section: Introductionmentioning
confidence: 93%